Indexes might not be in correction territory, but they're getting closer. Now's the time to consider what moves to make.
VIDEO ON MSN MONEY
High priced jeans offer huge margins turbo charging an already big opportunity in the stock of red hot Joe's Jeans.
Apple (AAPL) blew away earnings this week and shares road upward. High-end retail, too, has been doing well of late as proof that people are spending money again on the hot stuff -- whether technology or clothing -- they really want.
That bodes well for companies catering to that highly lucrative segment of the market. One of my favorite names with tremendous growth potential right now is Joe’s Jeans (JOEZ). The purveyor of expensive jeans is just beginning to explode.
I discovered the stock last year and recommended shares when the company was trading for only $.67 per share. Since that time the stock has appreciated in value by more than 300% to a current price of $2.76 per share. (I recently made Joe's one of my Top Stocks for 2010)
That 300% appreciation is only the beginning.
Run screaming for the fire exit if you own Netflix stock, because it's about to tumble
By Ed Elfenbein, editor of Crossing Wall Street.
Lots of folks on Wall Street want to know which stock to buy. Today, I want to look at the absolute worst one to buy. My friends, that stock is Netflix (NFLX).
Now before anyone says that I’m being mean to the company, please bear in mind that I’m not offering a judgment on the managers or the employees. There’s a big difference between a good company and a good stock. Netflix has a business record that anyone should be proud of. The stock, however, is terribly, terribly overpriced.
We're beginning to see the hits these companies are going to take, and it's brutal.
By Jim Cramer, TheStreet
You mean health care reform is bad for health care stocks? You mean that they get hurt by it? You mean people will sell them because of it?
That's what I am hearing all over the health care world this week. This is revelation time.
We got all comfortable thinking that there were nothing but winners in the health care world. Instead, we start hearing from everyone that numbers are too high because of the reforms. Abbott (ABT) said that Wednesday and we heard it definitively from Lilly (LLY) on Monday -- 35 cents worth of definitive -- and that's just plain nasty.
Apple's rapid upgrade cycle and loyal customers will help it surpass Exxon Mobil's market cap.
By Jason Schwarz, TheStreet
The key takeaway from Apple’s (AAPL) earnings report is that seasonality no longer affects the company. The company entered new territory when it sold 8.75 million iPhones in the first quarter, doubling the year-earlier quarter.
This company's hottest product is an iPhone that needs to be replaced every 18 to 24 months. Many analysts have overlooked that fact.
I realized it when Steve Jobs spent a few minutes at an iPad event explaining that Apple was now the world's No. 1 mobile device company. What does this really mean? It means that the lifecycle of its products is no longer seven years like it was for the Mac.
Trading commission OK'd 2 proposed futures exchanges, but Senate bill could derail plans
A day after the second movie-futures trading exchange received federal approval, the whole financial endeavor hit a major roadblock.
Legislation banning Wall Street trading of movie box office futures has been sent to the Senate floor, as part of the Wall Street Transparency and Accounting Act.
It could be voted on by the Senate as early as Thursday.
Calls are growing for a federal investigation of the company, particularly after its AdMob purchase.
But in the case of Google (GOOG), the latest call to action by Consumer Watchdog is one more piece of the antitrust puzzle being assembled to threaten the company.
Google is already in the sights of the Federal Trade Commission, according to The Wall Street Journal. Antitrust regulators are reportedly looking into the company's recent purchase of AdMob, a mobile phone advertising company.
Target, Macy's and Bloomingdale's store-brand credit cards will no longer be serviced by Visa.
In order to spur spending, retailers have been offering shoppers discounts off their total ticket after signing up for their store-brand credit cards. And more often than not, those cards carry the Visa (V) logo.
Well, some merchants appear to be tired of Visa skimming off the top of those sales. This week, Target (TGT) announced it will no longer issue cards with the Visa logo and instead encourage shoppers to sign up for its own plastic “REDcard.”
These oil companies are raising cash and drilling again, and their stocks are moving up.
By Jim Cramer, TheStreet
Have you noticed that the oil stocks are now higher than they were when oil hit its high? Have you noticed that the sector has far outstripped its last two runs into the $80s?
I think that's because the sector has growth in it. That's right, the oil companies, after sitting on their reserves or just letting them stagnate, are now spending again, drilling again, buying again, whether it be Apache (APA), Exxon Mobil (XOM), BP (BP) or Chevron (CVX), and we can see the bias causing the stocks to move.
BK classes up its menu with offerings like a ciabatta breakfast sandwich, but will it win over McDonald's customers?
Burger King is turning its battle with McDonald's (MCD) for early morning sales into a battle of words. In selected markets, the BK is advertising the availability of a "Burger King brunch." The move away from breakfast is apparently supposed to evoke ideas of higher quality than just a conventional meal of (perish the thought!) eggs and coffee.
The brunch menu is debuting in test markets that include Massachusetts, Florida and parts of Canada. But will it be enough to loosen Mickey D’s iron grip on breakfast sales?
Second company wins OK from federal regulators, but more approvals still needed.
The second of two financial companies looking to establish futures trading based on domestic box office performance of movies received regulatory approval Tuesday to set up a market.
The ruling from the Commodities Futures Trading Commission sanctions Cantor Fitzgerald to create the infrastructure for movie-futures trading.
Similar approval was given Friday to Chicago-based Media Derivatives.
Searching for chip sector profit? Check out lithography tools, which chipmakers spend a pretty penny on.
Talk about rebounds!
In 2010, Standard & Poor's is projecting that the company will make $2.41 per ADS.
The reason for the rebound is pretty simple:
These funds are hoping that smaller companies, which are more agile, can strike it rich as the economy recovers.
Exchange-traded fund (ETF) providers are pinning their hopes to these new small caps as the economy continues to recover. Many of these ETFs are tied to smaller companies in specific industries, such as utilities, materials or consumer staples.
"Small caps traditionally lead the way out of a recession," the president of one ETF firm told Index Universe.
Goldman Sachs has a shocking lack of respect for investors. But is anyone bothered by that?
That's been a hot topic of discussion this week as investors digest the news that the firm was hit by civil-fraud charges Friday. Goldman's stock fell by nearly 13% after news of the SEC complaint hit.
I think that most corporate news is generally already baked into a stock's price -- even before it's announced. But in this case, I'd say Goldman investors were unprepared for the bomb that dropped.
So should Goldman have told everyone?
Multi-manager funds sound like a good idea, but too many cooks in the kitchen can muddle a fund's performance and hurt your nest egg
By Dan Weiner, editor of Fund Focus Weekly
Vanguard announced last week that it's handing an 8.5% piece of the Vanguard Windsor II Fund (VWNFX) to Sanders Capital, and in particular John Mahedy, who used to work on Windsor when he was at AllianceBernstein.
Unfortunately, rather than give Mahedy and his team a mandate to run a value fund, Vanguard is simply continuing to add chefs to the Windsor II kitchen, and the meal gets less and less tasty with each one.
I’m one of the leading experts on Vanguard funds, so this is particularly irksome to me. But the bigger lesson that you can take away from the increasingly messy management of Windsor II is that multi-manager funds are almost always bad news for your 401k. And here’s why:
The Goldman probe halted the run-up, but we could be setting up for a move if earnings are good.
By Jim Cramer, TheStreet
Think about what you heard after the Goldman Sachs (GS) news on Friday: The public will think, again, the game is rigged and that the government is anti-business, deservedly, because the markets can't be trusted.
Most of all, you got a sense of the market's "fragility." No one would say, "It's time to buy." No one. My mailbox was full of end-of-the-world submissions; palpable hatred was back.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The company has made at least 4 acquisitions in the space, and few people have paid any attention.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The major averages finished the session on a modestly higher note, but not before heavy selling pressure sent the Nasdaq Composite (+0.3%) for a test of its 200-day moving average. The S&P 500, meanwhile, added 0.7% with all ten sectors posting gains.
Equities climbed at the open with the advance built on the relative strength of biotechnology and other momentum names. Despite the solid early gains in those areas, the market began fading from its high as multiple ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|